155 related articles for article (PubMed ID: 37972729)
1. Dissecting cell type-specific impact in lysosomal acid lipase deficiency-associated disorders.
Westerterp M; Li F; Zhang H
J Lipid Res; 2023 Dec; 64(12):100474. PubMed ID: 37972729
[No Abstract] [Full Text] [Related]
2. Hepatic cholesteryl ester accumulation in lysosomal acid lipase deficiency: non-invasive identification and treatment monitoring by magnetic resonance.
Thelwall PE; Smith FE; Leavitt MC; Canty D; Hu W; Hollingsworth KG; Thoma C; Trenell MI; Taylor R; Rutkowski JV; Blamire AM; Quinn AG
J Hepatol; 2013 Sep; 59(3):543-9. PubMed ID: 23624251
[TBL] [Abstract][Full Text] [Related]
3. Molecular defects underlying Wolman disease appear to be more heterogeneous than those resulting in cholesteryl ester storage disease.
Lohse P; Maas S; Sewell AC; van Diggelen OP ; Seidel D
J Lipid Res; 1999 Feb; 40(2):221-8. PubMed ID: 9925650
[TBL] [Abstract][Full Text] [Related]
4. Lysosomal lipase deficiency: molecular characterization of eleven patients with Wolman or cholesteryl ester storage disease.
Fasano T; Pisciotta L; Bocchi L; Guardamagna O; Assandro P; Rabacchi C; Zanoni P; Filocamo M; Bertolini S; Calandra S
Mol Genet Metab; 2012 Mar; 105(3):450-6. PubMed ID: 22227072
[TBL] [Abstract][Full Text] [Related]
5. A Case of Lysosomal Acid Lipase Deficiency Confirmed by Response to Sebelipase Alfa Therapy.
Shen JJ; Davis JL; Hong X; Laningham FH; Gelb MH; Kim GE
J Pediatr Gastroenterol Nutr; 2020 Dec; 71(6):726-730. PubMed ID: 32740531
[TBL] [Abstract][Full Text] [Related]
6. Lysosomal acid lipase: a pivotal enzyme in the pathogenesis of cholesteryl ester storage disease and Wolman disease.
Ameis D; Greten H
Z Gastroenterol; 1996 Jun; 34 Suppl 3():66-7. PubMed ID: 8767467
[No Abstract] [Full Text] [Related]
7. Extended use of a selective inhibitor of acid lipase for the diagnosis of Wolman disease and cholesteryl ester storage disease.
Civallero G; De Mari J; Bittar C; Burin M; Giugliani R
Gene; 2014 Apr; 539(1):154-6. PubMed ID: 24508470
[TBL] [Abstract][Full Text] [Related]
8. Genetic and biochemical evidence that CESD and Wolman disease are distinguished by residual lysosomal acid lipase activity.
Aslanidis C; Ries S; Fehringer P; Büchler C; Klima H; Schmitz G
Genomics; 1996 Apr; 33(1):85-93. PubMed ID: 8617513
[TBL] [Abstract][Full Text] [Related]
9. Lysosomal acid lipase deficiency: wolman disease and cholesteryl ester storage disease.
Tylki-Szymańska A; Jurecka A
Pril (Makedon Akad Nauk Umet Odd Med Nauki); 2014; 35(1):99-106. PubMed ID: 24798600
[TBL] [Abstract][Full Text] [Related]
10. Structural bases of Wolman disease and cholesteryl ester storage disease.
Saito S; Ohno K; Suzuki T; Sakuraba H
Mol Genet Metab; 2012 Feb; 105(2):244-8. PubMed ID: 22138108
[TBL] [Abstract][Full Text] [Related]
11. Intragenic deletion as a novel type of mutation in Wolman disease.
Lee TM; Welsh M; Benhamed S; Chung WK
Mol Genet Metab; 2011 Dec; 104(4):703-5. PubMed ID: 21963785
[TBL] [Abstract][Full Text] [Related]
12. Cholesteryl ester storage disease and Wolman disease: phenotypic variants of lysosomal acid cholesteryl ester hydrolase deficiency.
Hoeg JM; Demosky SJ; Pescovitz OH; Brewer HB
Am J Hum Genet; 1984 Nov; 36(6):1190-203. PubMed ID: 6097111
[TBL] [Abstract][Full Text] [Related]
13. In situ localization of the genetic locus encoding the lysosomal acid lipase/cholesteryl esterase (LIPA) deficient in Wolman disease to chromosome 10q23.2-q23.3.
Anderson RA; Rao N; Byrum RS; Rothschild CB; Bowden DW; Hayworth R; Pettenati M
Genomics; 1993 Jan; 15(1):245-7. PubMed ID: 8432549
[No Abstract] [Full Text] [Related]
14. Pediatric patients with lysosomal acid lipase deficiency.
Suarez-Zamora DA; Rojas-Rojas MM; Ordoñez-Guerrero F; Mugnier-Quijano J; Lopez-Panqueva R
Rev Esp Patol; 2023; 56(2):113-118. PubMed ID: 37061237
[TBL] [Abstract][Full Text] [Related]
15. Cholesteryl ester storage disease: protean presentations of lysosomal acid lipase deficiency.
Zhang B; Porto AF
J Pediatr Gastroenterol Nutr; 2013 Jun; 56(6):682-5. PubMed ID: 23403440
[TBL] [Abstract][Full Text] [Related]
16. Lysosomal Acid Lipase Deficiency: Genetics, Screening, and Preclinical Study.
Mashima R; Takada S
Int J Mol Sci; 2022 Dec; 23(24):. PubMed ID: 36555187
[TBL] [Abstract][Full Text] [Related]
17. Expression and functional characterization of human lysosomal acid lipase gene (LIPA) mutation responsible for cholesteryl ester storage disease (CESD) phenotype.
Rajamohan F; Reyes AR; Ruangsiriluk W; Hoth LR; Han S; Caspers N; Tu M; Ward J; Kurumbail RG
Protein Expr Purif; 2015 Jun; 110():22-9. PubMed ID: 25620107
[TBL] [Abstract][Full Text] [Related]
18. [Acid lipase deficiency: Wolman disease and cholesteryl ester storage disease].
Tanaka A
Nihon Rinsho; 1995 Dec; 53(12):3004-8. PubMed ID: 8577049
[TBL] [Abstract][Full Text] [Related]
19. Lysosomal acid lipase deficiency in pediatric patients: a scoping review.
Witeck CDR; Schmitz AC; de Oliveira JMD; Porporatti AL; De Luca Canto G; Pires MMS
J Pediatr (Rio J); 2022; 98(1):4-14. PubMed ID: 33964214
[TBL] [Abstract][Full Text] [Related]
20. Benefit of Treatment With Sebelipase-Alfa in a 63-Year-Old Patient With Advanced Liver and Atherosclerotic Disease Due to Lysosomal Acid Lipase Deficiency (LAL-D).
Aigner E; Feldman A; Neureiter D; Datz C; Ratziu V; Paulweber B
Am J Gastroenterol; 2018 Mar; 113(3):443-445. PubMed ID: 29535442
[No Abstract] [Full Text] [Related]
[Next] [New Search]
